Phase 3 Obesity and Overweight Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Obesity and Overweight
Metsera, a wholly owned subsidiary of Pfizer3,500 enrolled196 locationsNCT07311850
Recruiting
Phase 3
Effect of Semaglutide in Patients With Psoriasis and Obesity
Obesity and OverweightPsoriasis (PsO)
The University of Hong Kong14 enrolled1 locationNCT06937060
Completed
Phase 3
Effect of exercise intensity on cardiac and vascular function, and intra-abdominal fat in obese children and adolescents.
Obesity and overweight in children and adolescents
Professor Jeff Coombes60 enrolled1 locationACTRN12613001037796